SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device
Washington D.C., Dec. 18, 2020 — The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended...
Woman Convicted of Laundering Over $750,000 from Health Care Fraud Scheme
A federal jury convicted a Florida woman Friday for laundering approximately $786,000 in money stolen from Medicare, Medicaid, and private health insurers as part of a sprawling health care fraud scheme in Miami.
According to court documents and evidence presented at trial, Jesmina Ramirez, 50, of Miami Gardens, laundered hundreds of thousands of dollars in fraud proceeds by cashing checks...
NY Businessman convicted of $600M healthcare fraud scheme
A federal jury convicted a New York man this week in an over $600 million health care fraud, wire fraud, and identity theft scheme.
According to court documents and evidence presented at trial, Mathew James, 54, of East Northport, operated a medical billing company that billed for procedures that were either more serious or entirely different than those James’ doctor-clients...
Former Pfizer Statistician Charged with Insider Trading
Employee and friend traded ahead of Pfizer’s “game-changer” announcement on the success of its Paxlovid trial
Washington D.C. — The Securities and Exchange Commission has announced insider trading charges against Amit Dagar, a former Pfizer Inc. employee, and his close friend and business partner, Atul Bhiwapurkar, for trading in advance of the company’s November 5, 2021, announcement that a randomized,...